2022
DOI: 10.3201/eid2813.212248
|View full text |Cite
|
Sign up to set email alerts
|

Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic

Abstract: A network of global respiratory disease surveillance systems and partnerships has been built over decades as a direct response to the persistent threat of seasonal, zoonotic, and pandemic influenza. These efforts have been spearheaded by the World Health Organization, country ministries of health, the US Centers for Disease Control and Prevention, nongovernmental organizations, academic groups, and others. During the COVID-19 pandemic, the US Centers for Disease Control and Prevention worked closely with minis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 23 publications
0
9
0
Order By: Relevance
“…The substantial improvements in surveillance capacities supported by CDC ID in collaboration with WHO EMRO demonstrate commitment by national governments in EMR to prioritize programs for influenza surveillance, response, and preparedness and contribute data and specimens for consideration in global influenza vaccine composition recommendations. These capacities have served as the basis for the diagnosis and investigation of other infectious diseases, like Middle East respiratory syndrome coronavirus (MERS‐CoV), Ebola, and SARS‐CoV‐2 4,15 …”
Section: Evidence Of Expanded Regional Capacitiesmentioning
confidence: 99%
“…The substantial improvements in surveillance capacities supported by CDC ID in collaboration with WHO EMRO demonstrate commitment by national governments in EMR to prioritize programs for influenza surveillance, response, and preparedness and contribute data and specimens for consideration in global influenza vaccine composition recommendations. These capacities have served as the basis for the diagnosis and investigation of other infectious diseases, like Middle East respiratory syndrome coronavirus (MERS‐CoV), Ebola, and SARS‐CoV‐2 4,15 …”
Section: Evidence Of Expanded Regional Capacitiesmentioning
confidence: 99%
“…CDC has provided longstanding support to strengthen surveillance, health information, and laboratory systems globally. Examples of such platforms used during the COVID-19 pandemic include the early warning and response surveillance system ( 1 ); respiratory ( 2 ), influenza ( 3 ), and acute febrile illness surveillance systems ( 4 ); global health security–supported information systems (e.g., District Health Information Software, version 2 [DHIS2]) ( 5 ); and PEPFAR-supported HIV and tuberculosis (TB) information systems ( 6 , 7 ). Respiratory disease surveillance guidance was developed for COVID-19 in 9 temporary camps for displaced persons along the Thailand–Myanmar border, showing that such systems can be effective during pandemics ( 2 ).…”
Section: Surveillance Information and Laboratory Systemsmentioning
confidence: 99%
“…Respiratory disease surveillance guidance was developed for COVID-19 in 9 temporary camps for displaced persons along the Thailand–Myanmar border, showing that such systems can be effective during pandemics ( 2 ). Countries’ ministries of health (MOH), the World Health Organization (WHO), CDC, academic institutions, and nongovernmental organizations adapted international influenza surveillance systems for SARS-CoV-2 infections ( 3 ). CDC collaborated with MOH and partners to leverage existing acute febrile illness surveillance systems in 5 countries to collect and generate COVID-19 data needed for action ( 4 ).…”
Section: Surveillance Information and Laboratory Systemsmentioning
confidence: 99%
“…Later in the pandemic, the World Health Organization (WHO) produced interim guidance for countries to maintain or restart influenza surveillance as well as to monitor SARS-CoV-2 ( 10 ). As such, the implementation of genomic sequencing of SARS-CoV-2 from samples collected from representative sentinel sites was expedited to monitor the trends and prevalence of existing and emerging (co-)circulating genetic variants.…”
Section: Introductionmentioning
confidence: 99%